ASCENTAGE PHARMA GROUP(ASPHF)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

ASPHF ASCENTAGE PHARMA GROUP

休市中 01-09 16:00:00 EST 延时

{"stockData":{"symbol":"ASPHF","market":"US","secType":"STK","nameCN":"ASCENTAGE PHARMA GROUP","latestPrice":8.48,"timestamp":1767992400000,"preClose":8.48,"halted":0,"volume":0,"delay":15,"floatShares":286331303,"shares":371853475,"eps":-0.183888,"marketStatus":"休市中","change":0,"latestTime":"01-09 16:00:00 EST 延时","open":8.48,"high":8.48,"low":8.48,"amount":0,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"otc":true,"ttmEps":-0.183888,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1768208400000},"marketStatusCode":7,"adr":0,"exchange":"PINK LIMITED","adjPreClose":8.48,"volumeRatio":0.04132231541561373},"requestUrl":"/m/hq/s/ASPHF","defaultTab":"news","newsList":[{"id":"2602347075","title":"这家药企又一款新药临床申请获FDA许可，国际化发展持续加速","url":"https://stock-news.laohu8.com/highlight/detail?id=2602347075","media":"制药网","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2602347075?lang=zh_cn&edition=full","pubTime":"2026-01-08 15:42","pubTimestamp":1767858161,"startTime":"0","endTime":"0","summary":"近日，亚盛医药宣布BTK降解剂APG-3288的新药临床申请获美国FDA许可，将开展其治疗复发/难治B细胞恶性肿瘤的临床研究。截至目前，公司已共有4个在研新药获得16项FDA和1项欧盟孤儿药资格认定，2项FDA快速通道资格以及2项FDA儿童罕见病资格认证。业内预计，随着亚盛医药重磅品种临床的持续推进，以及与跨国药企及顶尖学术机构的深度合作。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260108160110a4ab1664&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260108160110a4ab1664&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IND","BK4139","ASPHF"],"gpt_icon":0},{"id":"2593434692","title":"亚盛医药盘中异动 早盘股价大跌5.49%报27.70美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2593434692","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2593434692?lang=zh_cn&edition=full","pubTime":"2025-12-23 00:30","pubTimestamp":1766421039,"startTime":"0","endTime":"0","summary":"北京时间2025年12月23日00时30分，亚盛医药股票出现异动，股价急速跳水5.49%。截至发稿，该股报27.70美元/股，成交量3048股，换手率0.00%，振幅3.00%。亚盛医药股票所在的生物技术行业中，整体涨幅为0.75%。其相关个股中，健永生技、Silexion Therapeutics Corp C/Wts Exp 15/08/2029 、Klotho Neurosciences Inc C/Wts 21/06/2029 涨幅较大，Pmgc Holdings Inc.、Psyence Biomedical Ltd.、Aditxt, Inc.较为活跃，换手率分别为141.64%、56.29%、30.64%，振幅较大的相关个股有Silexion Therapeutics Corp C/Wts Exp 15/08/2029 、健永生技、Apollomics Inc C/Wts 01/04/2028 ，振幅分别为343.55%、142.43%、103.24%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251223003040953b84fa&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251223003040953b84fa&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["06855","ASPHF","BK1574","BK1161"],"gpt_icon":0},{"id":"2552725281","title":"亚盛医药再涨超7%近期配股净筹超14.9亿港元利沙托克拉新药上市申请获批","url":"https://stock-news.laohu8.com/highlight/detail?id=2552725281","media":"动脉网","labels":["shareholding","productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2552725281?lang=zh_cn&edition=full","pubTime":"2025-07-17 10:06","pubTimestamp":1752717960,"startTime":"0","endTime":"0","summary":"亚盛医药-B股价涨超7%，配股筹14.93亿港元，新药利沙托克拉上市填补国内空白，全球商业化潜力大，有望成第二款获批的BCL-2抑制剂。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025071710152197a92516&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025071710152197a92516&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["AAPG","BK4139","ASPHF"],"gpt_icon":0},{"id":"2551188991","title":"亚盛医药拟配股筹资最多15.4亿港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2551188991","media":"DoNews","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2551188991?lang=zh_cn&edition=full","pubTime":"2025-07-14 19:13","pubTimestamp":1752491583,"startTime":"0","endTime":"0","summary":"2025年7月14日，交易文件显示，亚盛医药计划通过先旧后新方式配售股份，预计筹资至多15.4亿港元（约1.96亿美元）。公司拟配售2,200万股股份，每股配售价在68.35至70港元之间，较上周一收盘价74.70港元折让6.3%-8.5%。此次配股旨在增强公司资金流动性。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250714191420954206e8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250714191420954206e8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ASPHF","BK4139","06855","AAPG"],"gpt_icon":0},{"id":"2551927949","title":"亚盛医药利刃出鞘","url":"https://stock-news.laohu8.com/highlight/detail?id=2551927949","media":"药智网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2551927949?lang=zh_cn&edition=full","pubTime":"2025-07-14 09:43","pubTimestamp":1752457417,"startTime":"0","endTime":"0","summary":"近日，根据NMPA官网的消息，亚盛医药万众期待的管线利沙托克拉片已附条件批准上市，用于既往经过至少包含布鲁顿酪氨酸激酶抑制剂在内的一种系统治疗的成人慢性淋巴细胞白血病/小淋巴细胞淋巴瘤患者。利刃出鞘维奈克拉上市之后，近十年之久无后来者，而直到如今，第二款药物——利沙托克拉片才获批上市。亚盛医药的后备军作为一家目前市值已经较高的biotech，亚盛医药肯定不止奥雷巴替尼和APG-2575两个大单品支撑，后面肯定还有生力军。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250714094538a6a78424&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250714094538a6a78424&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["06855","AAPG","ASPHF","BK1574","BK1161"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.ascentagepharma.com","exchange":"PINK LIMITED","name":"ASCENTAGE PHARMA GROUP","nameEN":"ASCENTAGE PHARMA GROUP"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.36.0","shortVersion":"4.36.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"ASCENTAGE PHARMA GROUP(ASPHF)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供ASCENTAGE PHARMA GROUP(ASPHF)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"ASCENTAGE PHARMA GROUP,ASPHF,ASCENTAGE PHARMA GROUP股票,ASCENTAGE PHARMA GROUP股票老虎,ASCENTAGE PHARMA GROUP股票老虎国际,ASCENTAGE PHARMA GROUP行情,ASCENTAGE PHARMA GROUP股票行情,ASCENTAGE PHARMA GROUP股价,ASCENTAGE PHARMA GROUP股市,ASCENTAGE PHARMA GROUP股票价格,ASCENTAGE PHARMA GROUP股票交易,ASCENTAGE PHARMA GROUP股票购买,ASCENTAGE PHARMA GROUP股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"ASCENTAGE PHARMA GROUP(ASPHF)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供ASCENTAGE PHARMA GROUP(ASPHF)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}